Analysis Raises Questions about How Device Makers Label Patient Deaths
Medical device manufacturers are required to report any event that "reasonably suggests a device may have caused or contributed to a death or serious injury." Madris Tomes, a former FDA consultant, conducted an analysis showing that 4,000 patient deaths were labeled as “injuries” or “malfunctions” between 2011 and 2015. She says … [Read more...]
Cerebellar Atrophy Reported in Dilantin Patients
The U.S. Food and Drug Administration (FDA) has approved labeling changes stating that cerebellar atrophy has been reported in patients taking phenytoin. This nervous system adverse reaction appears to occur more frequently when drug levels are elevated or when it is used long-term. Phenytoin is sold by Pfizer under the brand name … [Read more...]
Epilepsy Drug Dilantin can Lead to SJS
The Side Effects of Dilatin. Dilantin (phenytoin) is a drug approved to treat epilepsy. It is available in a chewable form, called Dilantin Infatabs, often given to young children. One rare, but possible side effect associated with Dilantin is Stevens-Johnson Syndrome (SJS), a life-threatening reaction that affects the skin and … [Read more...]
Macrolide Antibiotic Use During Pregnancy Linked to Higher Risk of Cerebral Palsy and Epilepsy
Macrolide Antibiotic Risk Of Epilepsy Or Cerebral Palsy. New research suggests that the use of macrolide antibiotics during pregnancy could increase the risk of giving birth to a child with epilepsy or cerebral palsy. The study, which was conducted by researchers from the UCL Institute of Child Health (ICH) in London, was published … [Read more...]
Macrolide Antibiotics in Pregnancy Increase Baby’s Risk for Epilepsy or Cerebral Palsy
A new study from researchers at University College London reports a slightly increased risk of epilepsy or cerebral palsy for babies whose mothers take macrolide antibiotics during pregnancy. The study, from the UCL Institute of Child Health (ICH), was published online in PLOS One on March 25, 2015. The study follows evidence of … [Read more...]
Teenage Girl Suffers From Skin Reaction After Taking Epilepsy Medication
After Taking Lamictal And Keppra a Girl Suffered a life-threatening Skin Reaction. After taking Lamictal and Keppra to control her seizures, a girl from Sydney, Australia suffered a life-threatening skin reaction and nearly dies on her 19th birthday, Daily Mail reports. The teenage girl suffered from Stevens-Johnson Syndrome (SJS) … [Read more...]
Young Boy Suffering from Stevens-Johnson Syndrome After Taking Epilepsy Drug
A boy Is Now Suffering From a severe SJS Reaction After Taking The Epilepsy Drug. A growing number of drugs have been tied to the very serious and, sometimes, fatal allergic reaction, Stevens-Johnson Syndrome (SJS). Now, a seven-year-old boy is suffering from a very severe SJS reaction after taking the epilepsy drug, Tegretol … [Read more...]
Restrictions on Epilepsy Drug Trobalt
Epilepsy Medication Trobalt Strictly Recommended On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended restricting the epilepsy medication Trobalt (retigabine) because of side effects, including impaired vision. The EMA now recommends that physicians prescribe … [Read more...]
GlaxoSmithKline Recalls Epilepsy Drug
Epilepsy Drug Lamictal Are Being Recalled. GlaxoSmithKline is recalling about 100,000 starter kits of Lamictal, a drug used to treat epilepsy and bipolar disorder. The pharmaceutical giant said the wrong dosage was found in two of the kits. The kits are designed so that patients gradually increase their dosage of the drug over … [Read more...]
2 Epilepsy Drugs Birth Defects Risk
Epilepsy Drugs Birth Defects. A new analysis of two drugs widely used to control epilepsy, manage bipolar disorder and alleviate migraines shows up to a five-fold increase in the risk of major birth defects, researchers said Tuesday. Both drugs already carry warnings against use by pregnant women, but the risk had not been … [Read more...]
